Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New eye pressure checker matches gold standard in small study

NCT ID NCT07152808

Diagnosis Sponsor: Nidek Co. LTD. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed pilot study tested whether the Nidek TONOREF III, a device that measures eye pressure and other eye features, gives results similar to the standard Goldmann tonometer. Fifty-two adults had their eye pressure measured with both devices to check for agreement. The goal was to show the new device is as accurate and safe as the current standard.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

52 people

The number who actually took part.

Started

Sep 2022

Finished

Jun 2023

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Each subject had to have: 1. been at least 22 years of age of either sex and any race or ethnicity; 2. been willing and able to provide written informed consent prior to any study procedures being performed; 3. been willing and able to follow all instructions and attend all study visits; 4. corneal astigmatism of ≤3D and corneal thickness of 500-600 μm in at least one eye. Exclusion Criteria: Each subject had to not to : 1. have only one functional eye; 2. have poor or eccentric fixation in the study eye; 3. have corneal scarring or have had corneal surgery, including corneal laser surgery in the study eye 4. have microphthalmos in the study eye; 5. have buphthalmos in the study eye; 6. be a contact lens wearer in the study eye; 7. have dry eyes; 8. be a lid squeezer - blepharospasm; 9. have nystagmus in the study eye; 10. have keratoconus in the study eye; 11. have any other corneal or conjunctival pathology or infection in the study eye; 12. use medication that affect IOP; 13. current participation in other clinical trials; 14. have a condition or a situation, which in the Investigator's opinion, may put the subject at increased risk, confound study data, or interfere significantly with the subject's study participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intraocular pressure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ocular hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Intraocular pressure

More trials for these conditions

Other studies related to the condition(s) this trial covers.